Anumana Gains FDA Clearance for ECG-AI Amyloidosis Tool
CAMBRIDGE, Mass., April 8, 2026 Anumana, Inc. has received U.S. FDA clearance for its ECG-AI™ algorithm designed to detect...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
CAMBRIDGE, Mass., April 8, 2026 Anumana, Inc. has received U.S. FDA clearance for its ECG-AI™ algorithm designed to detect...
SAN ANTONIO, Texas, United States, April 7, 2026 bioAffinity Technologies, Inc. announced that its CyPath® Lung diagnostic test will...
Louisville, Colorado, USA | March 20, 2026 Biodesix Inc. has announced the publication of the largest lung nodule biomarker...
Phoenix, AZ – October 27, 2025: Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company, has issued...
PARIS – October 24, 2025 Sanofi reported a 7.0% sales increase at constant exchange rates (CER) for Q3 2025,...
BURLINGTON, N.C. – October 23, 2025 Labcorp (NYSE: LH), a global leader in laboratory diagnostics, announced it will soon...
SAN DIEGO, Sept. 25, 2025 — ClearNote Health announced that it has received UK Conformity Assessed (UKCA) approval for...
INDIANAPOLIS, Sept. 9, 2025, Eli Lilly and Company (NYSE: LLY) has launched a new global initiative, “Brain Health Matters,”...
